A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT06313996 · WITHDRAWN
Trial details
- NCT number
- NCT06313996
- Sponsor
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-29
- Primary completion
- 2031-10-16
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.